Medicare will pay for Kisunla for monoclonal antibodies directed against amyloid for the treatment of Alzheimer's disease. Please review this article and pay close attention to the billing instructions detailed within.
Effective January 1, 2024, IOP services are available for both individuals with mental health conditions and individuals with substance use disorders. This article addresses institutional billing requirements for these new services.
The Jimmo Settlement Agreement clarifies Medicare’s longstanding policy coverage of skilled nursing and skilled therapy services. Please read this article and access the link within the article for more information.
The interest period begins on the day after payment is due and ends on the day of payment. The new rate of 4.625% is in effect January through July 2025.
Medicare covers behavioral, mental and psychiatric health services that may improve outcomes for Medicare patients. For more information, please view this article and share these valuable resources and references with your patients.